Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

‘Statement: Zantac (ranitidine) U.S. litigation | GSK’ – gsk.com

https://www.gsk.com/en-gb/media/press-releases/statement-zantac-ranitidine-us-litigation/
byBenzinga Newsdesk
August 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://www.gsk.com/en-gb/media/press-releases/statement-zantac-ranitidine-us-litigation/

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0